Your 50s are when bone health stops being theoretical. This is when the body's bone biology shifts — sometimes dramatically — and when the choices you make have the most impact on what your skeleton looks like at 70, 80, and beyond.
Bone is living tissue, constantly being broken down by cells called osteoclasts and rebuilt by osteoblasts. Estrogen plays a critical regulatory role in this cycle — it essentially puts a brake on osteoclast activity, slowing the rate at which old bone is removed. When estrogen levels drop during menopause, that brake releases.
The result is an accelerated phase of bone loss. In the first five years after menopause, women can lose 2–3% of bone mineral density per year — significantly faster than the roughly 0.5–1% per year that occurs during normal aging. Over a decade, that adds up to a substantial reduction in bone strength.
This isn't universal — the rate varies considerably between individuals based on genetics, body composition, lifestyle, and how severe the hormonal shift is. But the general pattern is consistent enough that early menopause (before age 45) is recognized as a meaningful risk factor for osteoporosis, and the period immediately following menopause is when intervention has the highest potential impact.
Men aren't exempt from age-related bone loss — it's just slower and more gradual. Testosterone contributes to bone density in several ways: directly, and also indirectly, because some testosterone is converted to estradiol (a form of estrogen) in the body, and that estradiol also helps maintain bone. As testosterone levels decline with age — typically starting in a man's 40s and continuing through his 50s, 60s, and beyond — bone density follows, usually at a rate of about 0.5–1% per year.
Men with hypogonadism (clinically low testosterone) lose bone faster, and this is a treatable condition. But even men with testosterone in the lower end of normal ranges experience meaningful bone loss over time. By their 70s, men face substantial fracture risk — a fact that often goes unacknowledged.
The five years immediately following menopause represent the period of fastest bone loss for most women. This is also when lifestyle interventions — resistance training, calcium and vitamin D optimization, fall prevention — have the most leverage. Waiting until a fracture occurs means waiting until significant bone loss has already happened.
This doesn't mean that nothing can be done later. Bone responds to resistance training at any age. Medications can slow or reverse loss even in people with established osteoporosis. But earlier action means less ground to recover.
For men, there's no equivalent single "window," but the 60s and early 70s are typically when cumulative loss starts to translate into real fracture risk. This is when screening and assessment become particularly important.
A DEXA scan measures your bone mineral density at the hip and spine and gives you a T-score — a number that tells you how your density compares to a young adult reference. You can't make good decisions about bone health without knowing where you stand. In Canada, coverage varies by province and eligibility criteria, but post-menopausal women and men with risk factors can often access one through their GP.
See our detailed guide to DEXA scans in Canada — including provincial coverage, what your T-score means, and when to retest.
These aren't glamorous, but they matter. Bone requires calcium as a primary structural mineral, and vitamin D is essential for calcium absorption in the gut. Without adequate vitamin D, your body can't effectively use the calcium you consume regardless of how much you eat.
Osteoporosis Canada recommends 1,200 mg of calcium daily for adults over 50 (from food and supplements combined) and 800–2,000 IU of vitamin D. Most Canadians are deficient in vitamin D by late fall and winter — our latitude means we simply don't get enough sun. A blood test can confirm your status and help guide supplementation. See our calcium guide for specifics on getting enough through food first.
Bone responds to mechanical load. When you put stress on a bone through weight-bearing exercise and resistance training, the bone adapts by becoming denser. This is the most powerful modifiable factor in your bone health equation — more impactful than any supplement.
The research is clear: resistance training (lifting weights, using resistance bands, bodyweight exercises like squats and push-ups) increases bone density at the sites being loaded. Hip-targeted exercises matter for hip fracture risk; spine-loaded exercises matter for vertebral fractures. Consistency matters more than intensity — a program you stick with for years beats an aggressive program you abandon in months.
Walking is good for general health but isn't sufficient alone for bone density. It doesn't create enough mechanical stimulus. You need loading that challenges your muscles and, through them, your bones.
Fractures don't happen from low bone density alone — they happen when low-density bones meet falls. Balance training, proprioception work, and lower-body strength exercises all reduce fall risk, and reducing fall risk matters enormously. Tai chi has reasonable evidence behind it for fall prevention in older adults. So does targeted balance training. This is worth discussing with a physiotherapist if you're uncertain where to start.
Not everyone with bone loss needs medication. The decision depends on your fracture risk, not just your bone density number. Canadian guidelines use a tool called FRAX (Fracture Risk Assessment Tool) to estimate a person's 10-year probability of major osteoporotic fracture, factoring in age, sex, bone density, weight, smoking, alcohol use, family history, and other variables.
Doctors generally consider medication when:
Bisphosphonates are the most commonly prescribed class of medications for osteoporosis. They include alendronate (brand name Fosamax), risedronate (Actonel), and zoledronic acid (Reclast, given by infusion). They work by inhibiting osteoclasts — the cells that break down bone. By slowing bone resorption, bisphosphonates allow bone formation to outpace breakdown, gradually increasing density.
They are generally taken weekly (for oral forms) or annually (for intravenous zoledronic acid). The evidence for fracture reduction is solid — bisphosphonates reduce vertebral fracture risk by roughly 40–70% and hip fracture risk by about 40% in high-risk individuals. They've been in use for decades and are well-characterized.
Side effects: oral bisphosphonates can cause upper GI irritation, so they need to be taken correctly (with a full glass of water, staying upright for 30–60 minutes after). A rare concern is osteonecrosis of the jaw (ONJ), which is most associated with high-dose IV bisphosphonate use for cancer, not the lower doses used for osteoporosis. Atypical femur fractures are another rare but real risk with very long-term use (7+ years) — this is why doctors sometimes recommend "drug holidays" after several years of treatment.
Osteoporosis has been framed as a women's health issue for so long that both patients and clinicians can miss it in men. The stats tell a different story: men account for about 25% of osteoporotic fractures in Canada, and they have worse outcomes after hip fracture than women do — higher rates of institutionalization and higher mortality.
Men over 70 should ask their doctor about bone density assessment. Men with specific risk factors — hypogonadism, long-term steroid use, heavy alcohol use, malabsorption conditions — should ask earlier. A DEXA scan takes 15 minutes. Not getting one because "that's a women's test" is a real health risk.
Treatment for men is less studied than for women, but bisphosphonates work similarly in men, and the evidence for lifestyle interventions (resistance training, calcium, vitamin D) is equally strong. Men with documented hypogonadism may benefit from testosterone therapy — a separate conversation with an endocrinologist or urologist.
Hormone replacement therapy (HRT) — estrogen alone for women without a uterus, or estrogen plus progestin for those with one — maintains bone density and reduces fracture risk. This is well-established. HRT essentially replaces what menopause removes, and bone responds accordingly. Studies from the Women's Health Initiative and others have confirmed that HRT prevents both vertebral and hip fractures.
The question isn't whether it works for bone — it does. The question is whether the bone benefit justifies HRT given other considerations.
The trade-offs are real and should be discussed with a physician:
Current guidelines generally support HRT for menopausal symptom management in healthy women under 60 who are within 10 years of menopause onset, with bone protection as a concurrent benefit. For women who are primarily motivated by bone protection (not symptoms), the picture is more nuanced, and bisphosphonates or other bone-specific medications may be preferable.
This is not a decision to make based on a website. It requires a conversation with a physician who knows your full health history, your family history, and your risk tolerance.